Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

52.32 +0.86 (+1.67%)
Streaming Delayed Price Updated: 1:20 PM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 778,715
Open 51.95
Bid (Size) 52.30 (100)
Ask (Size) 52.35 (500)
Prev. Close 51.46
Today's Range 51.81 - 52.76
52wk Range 50.76 - 73.51
Shares Outstanding 183,352,255
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Cash-Producing Stocks with Promising Prospects
Free cash flow is one of the most reliable indicators of financial durability. These businesses not only generate cash but reinvest intelligently to sustain momentum. 
Via StockStory
This Zimmer Biomet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
 
Via Benzinga

Performance

YTD
-21.3%
-21.3%
1 Month
N/A
N/A
3 Month
-7.9%
-7.9%
6 Month
-14.7%
-14.7%
1 Year
-21.2%
-21.2%

More News

Read More
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) Presents a Compelling Value Investment Case
Via Chartmill
The 5 Most Interesting Analyst Questions From BioMarin Pharmaceutical’s Q3 Earnings Call
Via StockStory
Topics Earnings
Why BioMarin Pharmaceutical Stock Topped the Market on Tuesday
Via The Motley Fool
Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today
Via StockStory
Topics Earnings Economy Government
Biomarin Pharmaceutical Analysts Cut Their Forecasts After Downbeat Earnings
Via Benzinga
BMRN Q3 Deep Dive: Product Expansion and Portfolio Shifts Define Outlook
Via StockStory
BioMarin (BMRN) Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Reports Mixed Q3 2025 Results with Revenue Growth but Earnings Miss
Via Chartmill
Topics Earnings
BioMarin Pharmaceutical (NASDAQ:BMRN) Posts Q3 Sales In Line With Estimates
Via StockStory
BioMarin Pharmaceutical (BMRN) Reports Q3: Everything You Need To Know Ahead Of Earnings
Via StockStory
Topics Artificial Intelligence
Earnings Scheduled For October 27, 2025
Via Benzinga
What to Expect from Biomarin Pharmaceutical's Earnings
Via Benzinga
3 of Wall Street’s Favorite Stocks to Target This Week
Via StockStory
1 Healthcare Stock Worth Investigating and 2 We Question
Via StockStory
Topics Stocks
1 Mid-Cap Stock to Research Further and 2 That Underwhelm
Via StockStory
10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy Government World Trade
Is BioMarin Pharmaceutical Inc Gaining or Losing Market Support?
Via Benzinga
6 Analysts Assess BioMarin Pharmaceutical: What You Need To Know
Via Benzinga
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Presents a Compelling Value Investment Case
Via Chartmill
Peering Into BioMarin Pharmaceutical's Recent Short Interest
Via Benzinga
2 Profitable Stocks on Our Watchlist and 1 We Turn Down
Via StockStory
Reflecting On Therapeutics Stocks’ Q2 Earnings: BioMarin Pharmaceutical (NASDAQ:BMRN)
Via StockStory
Topics Artificial Intelligence
PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment
Via Benzinga

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?
Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.
What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?
BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?
The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market
What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?
The current price of BioMarin Pharmaceutical Inc. - Common Stock is 52.32
When was BioMarin Pharmaceutical Inc. - Common Stock last traded?
The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 11/10/25 01:20 PM ET
What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?
The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 9.59B
How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?
BioMarin Pharmaceutical Inc. - Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.